Skip to main content

Table 4 Comparative analysis of early recurrence predictive value of MCM6 and AFP

From: MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence

parameters

AUC (95%CI)

Cut-off value

Sensitivity

Specificity

Preoperative MCM6

0.513 (0.300–0.726)

941.635 (pg/ml)

64.3%

58.8%

Postoperative MCM6

0.773 (0.594–0.953)

941.635 (pg/ml)

78.6%

76.5%

Postoperative AFP

0.681 (0.474–0.887)

20.0 (ng/ml)

71.4%

41.2%

Postoperative (MCM6 & AFP)

_

_

80.1%

77.0%